Adaptor protein Ruk/CIN85 modulates resistance to doxorubicin of murine 4T1 breast cancer cells
Author:
Publisher
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka)
Subject
Biochemistry
Reference33 articles.
1. Personalised cancer medicine.;Jackson;Int J Cancer,2015
2. Combining immunotherapy and targeted therapies in cancer treatment.;Vanneman;Nat Rev Cancer,2012
3. Cancer stem cell targeted therapy: progress amid controversies.;Wang;Oncotarget,2015
4. Small molecule compounds targeting miRNAs for cancer therapy.;Monroig Pdel;Adv Drug Deliv Rev,2015
5. Novel delivery approaches for cancer therapeutics.;Mitra;J Control Release,2015
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. INCREASED EXPRESSION LEVEL OF ADAPTOR PROTEIN Ruk/CIN85 IN DOXORUBICIN-RESISTANT HUMAN NON-SMALL LUNG ADENOCARCINOMA MOR CELLS IS ASSOCIATED WITH THEIR METABOLIC REPROGRAMMING;Biotechnologia Acta;2023-04-28
2. Calix[4]arene chalcone amide C-1011 elicits differential effects on the viability of 4T1 mouse breast adenocarcinoma cells with different levels of adaptor protein Ruk/CIN85 expression;The Ukrainian Biochemical Journal;2022-07-11
3. THE ACQUISITION OF RESISTANCE IN HUMAN NON-SMALL LUNG ADENOCARCINOMA MOR CELLS IS ASSOCIATED WITH UP-REGULATION OF ADAPTOR PROTEIN RUK/CIN85 AND EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT);Biotechnologia Acta;2022-04
4. Adaptor protein Ruk/CIN85 modulates manifestation of cancer stem cells (CSCs) features in mouse breast adenocarcinoma 4T1 cells;Reports of the National Academy of Sciences of Ukraine;2018-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3